A small, preliminary study investigating the relationship between multiple sclerosis and the Epstein-Barr virus suggests a potential novel treatment for progressive multiple sclerosis.
Research demonstrates a daily dose of cannabidiol may help reduce seizures in children and adults suffering from Lennox- Gastaut syndrome (LGS).
Study participants receiving apomorphine also gave their treatment higher effectiveness scores than those who received the placebo.
Two anticancer and antidepressant drugs have been found to block a translational repression pathway that has previously been linked to neurodegeneration.
Researchers have developed computer models to further understanding the behavior of protein fragments and fibril aggregation in Huntington’s disease development.
Deep brain stimulation could significantly reduce the severity of both motor and phonic tics in young adults with Tourette’s syndrome.
NIH researchers look to a zebrafish model to improve our understanding of the blood–brain barrier’s neuroprotective cells.
In new research, the first live-attenuated Zika vaccine has been demonstrated to protected mice against the virus after a single dose.
According to new research, the antibiotic disrupts creation of fear memories in the brain, which could be utilized for treatment or prevention of post-traumatic stress disorder.
Authors also claim that stress-reduction techniques could be an effective low-risk treatment for sufferers.